# OR6S1

## Overview
The OR6S1 gene encodes the olfactory receptor family 6 subfamily S member 1, a protein that belongs to the G-protein-coupled receptor (GPCR) superfamily. These receptors are integral membrane proteins characterized by their seven-transmembrane domain structure, which is crucial for their role in signal transduction. The OR6S1 protein is primarily involved in the detection of odor molecules, functioning within the olfactory epithelium to bind specific odorants and initiate a signaling cascade that leads to the perception of smell (Alonso2008Overdominance). Beyond its role in olfaction, OR6S1 is also expressed in non-olfactory tissues, such as the skin, where it may contribute to processes like epidermal proliferation and regeneration (Uehara2021Non‐invasive). The gene has been studied for its potential involvement in various physiological and pathological contexts, including its differential methylation in HPV-positive oropharyngeal squamous cell carcinoma and its possible influence on HIV-1 susceptibility (Thami2023Whole; Ren2018Discovery).

## Structure
The OR6S1 gene encodes an olfactory receptor protein that is part of the G-protein-coupled receptor (GPCR) family. These receptors are characterized by a seven-transmembrane domain structure, which is essential for their role in signal transduction. The primary structure of the OR6S1 protein consists of a sequence of amino acids that form the basis for its function as an olfactory receptor. The secondary structure includes alpha helices, which are typical of GPCRs and contribute to the formation of the transmembrane domains. The tertiary structure involves the three-dimensional folding of these helices, allowing the receptor to interact with odorant molecules and initiate a cellular response. 

Post-translational modifications such as glycosylation and phosphorylation may occur, influencing the receptor's function and localization within the cell membrane. These modifications can affect the receptor's ability to bind to ligands and its overall stability. The OR6S1 protein functions as a monomer, and thus, quaternary structure is generally not applicable to this receptor (Manduchi2017Leveraging; Burkitt2023Role).

## Function
The OR6S1 gene encodes an olfactory receptor protein that is part of the G-protein-coupled receptor (GPCR) family, which plays a crucial role in the detection of odor molecules. These receptors are primarily active in the olfactory epithelium, where they bind specific odorants, initiating a signal transduction pathway that results in the perception of smell (Alonso2008Overdominance). The diversity of olfactory receptors, including OR6S1, is thought to enhance olfactory acuity by increasing the number of different odorant-binding sites encoded in the genome, allowing individuals to discriminate among closely related odorants more effectively (Alonso2008Overdominance).

In addition to their role in olfaction, olfactory receptors like OR6S1 are also expressed in other tissues, including the skin, where they may be involved in processes such as epidermal proliferation, migration, and regeneration (Uehara2021Non‐invasive). The expression of OR genes in the skin has been linked to epidermal homeostasis, and changes in their expression levels have been associated with conditions like sensitive skin (Uehara2021Non‐invasive). This suggests that OR6S1 may have broader biological roles beyond olfaction, contributing to various physiological processes in the body.

## Clinical Significance
The OR6S1 gene has been studied in the context of human papillomavirus (HPV)-positive oropharyngeal squamous cell carcinoma (OPSCC). Research has identified OR6S1 as one of the top candidates for differentially methylated regions (DMRs) in HPV-positive OPSCC, with significantly higher methylation levels in tumor samples compared to controls. This suggests a potential role in the carcinogenesis of HPV-positive OPSCC, where its methylation status could serve as a biomarker for distinguishing cancerous tissues from normal ones (Ren2018Discovery). 

In addition to its role in cancer, the OR6S1 gene has been implicated in genetic studies related to HIV-1 susceptibility. A study on the genetic diversity in the Botswana population found variations in the OR6S1 gene that may influence genetic predisposition or resistance to HIV-1, indicating potential differing effects related to HIV-1 susceptibility or resistance (Thami2023Whole).

Despite these findings, specific diseases or conditions directly resulting from mutations or expression alterations in the OR6S1 gene are not well-documented, and further research is needed to fully understand its clinical significance.


## References


[1. (Manduchi2017Leveraging) Elisabetta Manduchi, Alessandra Chesi, Molly A. Hall, Struan F.A. Grant, and Jason H. Moore. Leveraging putative enhancer-promoter interactions to investigate two-way epistasis in type 2 diabetes gwas. In Biocomputing 2018, 548–558. WORLD SCIENTIFIC, November 2017. URL: http://dx.doi.org/10.1142/9789813235533_0050, doi:10.1142/9789813235533_0050. This article has 0 citations.](https://doi.org/10.1142/9789813235533_0050)

[2. (Alonso2008Overdominance) S. Alonso, S. Lopez, N. Izagirre, and C. de la Rua. Overdominance in the human genome and olfactory receptor activity. Molecular Biology and Evolution, 25(5):997–1001, February 2008. URL: http://dx.doi.org/10.1093/molbev/msn049, doi:10.1093/molbev/msn049. This article has 43 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1093/molbev/msn049)

[3. (Uehara2021Non‐invasive) Yuya Uehara, Takayoshi Inoue, Noriyasu Ota, Shigaku Ikeda, and Takatoshi Murase. Non‐invasive evaluation of subjective sensitive skin by transcriptomics using mrna in skin surface lipids. Experimental Dermatology, 31(2):172–181, September 2021. URL: http://dx.doi.org/10.1111/exd.14459, doi:10.1111/exd.14459. This article has 5 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1111/exd.14459)

[4. (Burkitt2023Role) Kyunghee Burkitt. Role of dna methylation profiles as potential biomarkers and novel therapeutic targets in head and neck cancer. Cancers, 15(19):4685, September 2023. URL: http://dx.doi.org/10.3390/cancers15194685, doi:10.3390/cancers15194685. This article has 2 citations and is from a peer-reviewed journal.](https://doi.org/10.3390/cancers15194685)

[5. (Thami2023Whole) Prisca K. Thami, Wonderful T. Choga, Collet Dandara, Stephen J. O’Brien, Myron Essex, Simani Gaseitsiwe, and Emile R. Chimusa. Whole genome sequencing reveals population diversity and variation in hiv-1 specific host genes. Frontiers in Genetics, December 2023. URL: http://dx.doi.org/10.3389/fgene.2023.1290624, doi:10.3389/fgene.2023.1290624. This article has 0 citations and is from a peer-reviewed journal.](https://doi.org/10.3389/fgene.2023.1290624)

[6. (Ren2018Discovery) Shuling Ren, Daria Gaykalova, Jennifer Wang, Theresa Guo, Ludmila Danilova, Alexander Favorov, Elana Fertig, Justin Bishop, Zubair Khan, Emily Flam, Piotr T. Wysocki, Peter DeJong, Mizuo Ando, Chao Liu, Akihiro Sakai, Takahito Fukusumi, Sunny Haft, Sayed Sadat, and Joseph A. Califano. Discovery and development of differentially methylated regions in human papillomavirus‐related oropharyngeal squamous cell carcinoma. International Journal of Cancer, 143(10):2425–2436, September 2018. URL: http://dx.doi.org/10.1002/ijc.31778, doi:10.1002/ijc.31778. This article has 33 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1002/ijc.31778)